Helping young people start prep for hiv prevention
Part of Infections clinical trials.
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 13 and 24 years old.
- You have had vaginal or anal sex in the past year.
- You are not living with HIV.
- You weigh at least 77 pounds (35 kilograms).
- You are willing to get your PrEP care at a participating clinic or a community spot.
- You have a smartphone (iPhone or Android) and can read, speak, and understand English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different ways to help young men learn about and choose PrEP, a medicine that prevents HIV. It aims to see which approach works best for starting and staying on PrEP.
This study is for people who are HIV-negative and want to take PrEP (a daily pill that prevents HIV). It will help researchers learn more about how to best support people taking PrEP in real-world settings.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
This study tests how to better support HIV prevention for people who inject drugs and are newly starting PrEP (medicine to prevent HIV). It focuses on people taking medication for opioid use disorder and who have mild thinking and memory problems, to help them stay safe and adhere to prevention.
This study looks at how well a daily HIV prevention pill (F/TAF) works for people who use drugs. It also includes interviews with healthcare providers and peer navigators to understand how to better support patients.
This study tests a program to help men who have sex with men start and stick with PrEP, a daily pill that prevents HIV. It aims to make PrEP easier to use and reduce HIV risk.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.